Mechanical induction of the tumorigenic b-catenin pathway by tumour growth pressure

Nature

Volumn 523, Issue 7558, 2015, Pages 92-95

  Fernandez Sanchez, Marıa Elena ^a   Barbier, Sandrine ^a   Whitehead, Joanne ^a   Bealle, Gaelle ^b   Michel, Aude ^b   Latorre Ossa, Heldmuth ^c   Rey, Colette ^b   Fouassier, Laura ^b   Claperon, Audrey ^b   Brulle, Laura ^d   Girard, Elodie ^e   Servant, Nicolas ^e   Rio Frio, Thomas ^f   Lesieur, Sylviane ^g   Housset, Chantal ^b   Gennisson, Jean Luc ^c   Tanter, MickaeL ^c   Menager, Christine ^b   Fre, Silvia ^h   Robine, Sylvie ^f   Farge, Emmanuel ^a   more..

^a PSL RESEARCH UNIVERSITY   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d CNRS UMR3666   (France)

^e PSL RESEARCH UNIVERSITY   (France)

^f INSTITUT CURIE   (France)

^g UNIV PARIS SUD   (France)

^h INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; METAL NANOPARTICLE; NOTCH RECEPTOR; PROTEIN RET; RET PROTEIN, MOUSE;

ACTIVE TRANSPORT; ANIMAL; C57BL MOUSE; CARCINOGENESIS; COLON TUMOR; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MAGNET; MALE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PRESSURE; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BETA CATENIN; CARCINOGENESIS; COLONIC NEOPLASMS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAGNETS; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PRESSURE; PROTO-ONCOGENE PROTEINS C-RET; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84938494049     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/NATURE14329     Document Type: Letter

References (51)

1. Ghajar, C. M. & Bissell, M. J. Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging. Histochem. Cell Biol. 130, 1105–1118 (2008).
2. Butcher, D. T., Alliston, T. & Weaver, V. M. A tense situation: forcing tumour progression. Nat. Rev. Cancer 9, 108–122 (2009).
3. Sawada, Y. et al. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 127, 1015–1026 (2006).
4. Wozniak, M. A. & Chen, C. S. Mechano-tranduction: a growing role for contractibility. Nature Rev. Mol. Cell Biol. 10, 34–43 (2009).
5. Grashoff, C. et al. Measuringmechanical tension across vinculin reveals regulation of focal adhesion dynamics. Nature 466, 263–266 (2010).
6. Mammoto, A. et al. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457, 1103–1108 (2009).
7. Fre, S. et al. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc. Natl Acad. Sci. USA 106, 6309–6314 (2009).
8. Delarue, M. et al. Mechanical control of cell flow in multicellular spheroids. Phys. Rev. Lett. 110, 138103 (2013).
9. Stylianopoulos, T. et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc. Natl Acad. Sci. USA 109, 15101–15108 (2012).
10. Whitehead, J. et al. Mechanical factors activate b-catenin-dependent oncogene expression in APC mouse colon. HFSP J. 2, 286–294 (2008).
11. Jho, E. H. et al. Wnt/b-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22, 1172–1183 (2002).
12. Kahlert, U. D. et al. Activation of canonical WNT/b-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Lett. 325, 42–53 (2012).
13. van Veelen, W. et al. b-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis. Gut 60, 1204–1212 (2011).
14. Clevers, H. Wnt/b-catenin signaling in development and disease. Cell 127, 469–480 (2006).
15. Smits, R. et al. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis 18, 321–327 (1997).
16. Stambolic, V. & Woodgett, J. R. Mitogen inactivation of glycogen synthase kinase-3 b in intact cells via serine 9 phosphorylation. Biochem. J. 303, 701–704 (1994).
17. Cohen, P. & Frame, S. The renaissance of GSK3. Nature Rev. Mol. Cell Biol. 2, 769–776 (2001).
18. Fodde, R. et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl Acad. Sci. USA 91, 8969–8973 (1994).
19. Massart, R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans. Magn. 17, 1247–1248 (1981).
20. Szoka, F. Jr & Papahadjopoulos, D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl Acad. Sci. USA 75, 4194–4198 (1978).
21. Bealle, G. et al. Ultra magnetic liposomes for MR imaging, targeting, and hyperthermia. Langmuir 28, 11834–11842 (2012).
22. Martina, M. S. et al. Generation of superparamagnetic liposomesrevealed as highly efficient MRI contrast agents for in vivo imaging. J. Am. Chem. Soc. 127, 10676–10685 (2005).
23. Martina, M. S. et al. Magnetic targeting of rhodamine-labeled superparamagnetic liposomes to solid tumors: in vivo tracking by fibered confocal fluorescence microscopy. Mol. Imaging 6, 140–146 (2007).
24. Plassat, V., Martina, M. S., Barratt, G., Menager, C. & Lesieur, S. Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution. Int. J. Pharm. 344, 118–127 (2007).
25. Martina, M.-S., Wilhelm, C. & Lesieur, S. The effect of magnetic targeting on the uptake of magnetic-fluid-loaded liposomes by human prostatic adenocarcinoma cells. Biomaterials 29, 4137–4145 (2008).
26. Plassat, V. et al. Anti-estrogen-loaded superparamagnetic liposomes for intracellularmagnetic targeting andtreatment of breast cancer tumors. Adv. Funct. Mater. 21, 83–92 (2011).
27. Bain, J., McLauchlan, H., Elliott, M. & Cohen, P. The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199–204 (2003).
28. Blake, R. A. et al. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20, 9018–9027 (2000).
29. Kim, D. W. et al. An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases. J. Clin. Endocrinol. Metab. 91, 4070–4076 (2006).
30. Langmuir, P. B. & Yver, A. Vandetanib for the treatment of thyroid cancer. Clin. Pharmacol. Ther. 91, 71–80 (2012).
31. Mologni, L., Redaelli, S., Morandi, A., Plaza-Menacho, I. & Gambacorti-Passerini, C. Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase. Mol. Cell. Endocrinol. 377, 1–6 (2013).
32. De Falco, V. et al. Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer. J. Clin. Endocrinol. Metab. 98, E811–E819 (2013).
33. Gennisson, J. L. & Cloutier, G. Sol-gel transition in agar-gelatin mixtures studied with transient elastography. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 53, 716–723 (2006).
34. Chamming’s, F., Latorre-Ossa, H., Lefre`re-Belda, M. A., Fitoussi, V., Quibel, T., Assayag, F.,Marangoni, E., Autret, G., Balvay, L., Pidial, L., Gennisson, J. L., Tanter, M., Cuenod, C. A., Clement, O. & Fournier, L. Shear wave elastography of tumor growth in a human breast cancer model with pathological correlation. Eur. Radiol. 23, 2079–2086 (2013).
35. Bercoff, J., Tanter, M.&Fink, M.Supersonic shearimaging:Anewtechnique for soft tissue elasticity mapping. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 51, 396–409 (2004).
36. Sarvazyan, A. P., Rudenko, O. V., Swanson, S. D., Fowlkes, J. B. & Emelianov, S. Y. Shearwave elasticityimaging:Anewultrasonic technology ofmedical diagnostics. Ultrasound Med. Biol. 24, 1419–1435 (1998).
37. Swanson, C. A. et al. A comparison of diets of blacks and whites in three areas of the United States. Nutr. Cancer 20, 153–165 (1993).
38. Goss, S. A., Johnston, R. L. & Dunn, F. Comprehensive compilation of empirical ultrasonic properties of mammalian tissues. J. Acoust. Soc. Am. 64, 423–457 (1978).
39. Greenleaf, J. F., Fatemi, M. & Insana, M. Selected methods for imaging elastic properties of biological tissues. Annu. Rev. Biomed. Eng. 5, 57–78 (2003).
40. Sarvazyan, A. et al. Biophysical bases of elasticity imaging. Acoustical Imaging 21, 223–240 (1995).
41. Gennisson, J. L. et al. Viscoelastic and anisotropic mechanical properties of in vivo muscle tissue assessed by supersonic shear imaging. Ultrasound Med. Biol. 36, 789–801 (2010).
42. Royer, D., Gennisson, J. L., Deffieux, T. & Tanter, M. On the elasticity of transverse isotropic soft tissues. J. Acoust. Soc. Am. 129, 2757–2760 (2011).
43. Gennisson, J. L., Grenier, N., Combe, C. & Tanter, M. Supersonic shear wave elastography of in vivo pig kidney: influence of blood pressure, urinary pressure and tissue anisotropy. Ultrasound Med. Biol. 38, 1559–1567 (2012).
44. Bercoff, J. et al. in 2008 IEEE Ultrasonics Symposium, Vols 1-4 and Appendix Ultrasonics Symposium 321–324 (2008).
45. Madsen, E. L. et al. Anthropomorphic breast phantoms for testing elastography systems. Ultrasound Med. Biol. 32, 857–874 (2006).
46. Ophir, J., Cespedes, I., Ponnekanti, H., Yazdi, Y. & Li, X. Elastography—a quantitative method for imaging the elasticity of biological tissues. Ultrason. Imaging 13, 111–134 (1991).
47. Latorre-Ossa, H., Gennisson, J.-L., De Brosses, E. & Tanter, M. Quantitative imaging of nonlinear shear modulus by combining static elastography and shear wave elastography. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 59, 833–839 (2012).
48. Righetti, R. et al. The feasibility of using poroelastographic techniques for distinguishing between normal and lymphedematous tissues in vivo. Phys. Med. Biol. 52, 6525–6541 (2007).
49. Schmittgen, T. D.& Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nature Protocols 3, 1101–1108 (2008).
50. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants fromhigh-throughput sequencing data.Nucleic Acid Res. 38, e164 (2010).
51. Levy, M. et al. Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials 32, 3988 (2011).